Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Swain

Showing results (431-440 of 532) with videos related to

Pageof 54
Sort By:
Clinical Transplantation|February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancerR P Gale, R E Park, R Dubois, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2015
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38Reena S Cecchini, Sandra M Swain, Joseph P Costantino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Breast Cancer Research and Treatment|October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxanePaula R Pohlmann, Deena Graham, Tianmin Wu, et al.
Journal of Proteome Research|February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapyJulia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
Plant, Cell & Environment|February 13, 2018
Zebularine treatment is associated with deletion of FT-B1 leading to an increase in spikelet number in bread wheatE Jean Finnegan, Brett Ford, Xiaomei Wallace, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2024
Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective StudyM Swain, A Budrukkar, V Murthy, et al.
The New England Journal of Medicine|December 14, 2011
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancerJosé Baselga, Javier Cortés, Sung-Bae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERsMelody Cobleigh, Denise A Yardley, Adam M Brufsky, et al.
Pageof 54

Showing results (431-440 of 532) with videos related to

Sort By:
Pageof 54
Clinical Transplantation|February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancerR P Gale, R E Park, R Dubois, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2015
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38Reena S Cecchini, Sandra M Swain, Joseph P Costantino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Breast Cancer Research and Treatment|October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxanePaula R Pohlmann, Deena Graham, Tianmin Wu, et al.
Journal of Proteome Research|February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapyJulia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
Plant, Cell & Environment|February 13, 2018
Zebularine treatment is associated with deletion of FT-B1 leading to an increase in spikelet number in bread wheatE Jean Finnegan, Brett Ford, Xiaomei Wallace, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2024
Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective StudyM Swain, A Budrukkar, V Murthy, et al.
The New England Journal of Medicine|December 14, 2011
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancerJosé Baselga, Javier Cortés, Sung-Bae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERsMelody Cobleigh, Denise A Yardley, Adam M Brufsky, et al.
Pageof 54